Prognostic Impact of Acute Beta-Blocker Therapy on Top of Aspirin and Angiotensin-Converting Enzyme Inhibitor Therapy in Consecutive Patients With ST-Elevation Acute Myocardial Infarction

Beta Blocker ◽

Enzyme Inhibitor ◽

Prognostic Impact ◽

Converting Enzyme ◽

Blocker Therapy ◽

St Elevation ◽

Faculty Opinions recommendation of Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1086763.539677 ◽

2007 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Myocardial Infarction ◽

Beta Blocker ◽

Enzyme Inhibitor ◽

Prognostic Impact ◽

Converting Enzyme ◽

Blocker Therapy ◽

St Elevation ◽

Aspirin, beta-blocker and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

ACC Current Journal Review ◽

10.1016/j.accreview.2003.08.055 ◽

2003 ◽

Vol 12 (5) ◽

pp. 17

Author(s):

A.K. Berger ◽

S. Duval ◽

H.M. Krumholz

Keyword(s):

Myocardial Infarction ◽

Renal Disease ◽

Beta Blocker ◽

End Stage Renal Disease ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Stage Renal Disease ◽

End Stage

Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction

The American Journal of Cardiology ◽

10.1016/s0002-9149(02)02767-4 ◽

2002 ◽

Vol 90 (10) ◽

pp. 1045-1049 ◽

Cited By ~ 20

Author(s):

Harm Wienbergen ◽

Rudolf Schiele ◽

Anselm Kai Gitt ◽

Claus Juenger ◽

Tobias Heer ◽

...

Keyword(s):

Myocardial Infarction ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors ◽

St Elevation ◽

Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)00572-2 ◽

2003 ◽

Vol 42 (2) ◽

pp. 201-208 ◽

Cited By ~ 221

Author(s):

Alan K Berger ◽

Sue Duval ◽

Harlan M Krumholz

Keyword(s):

Myocardial Infarction ◽

Renal Disease ◽

Beta Blocker ◽

End Stage Renal Disease ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Stage Renal Disease ◽

End Stage

Effect of Combined Beta-Blocker and Angiotensin-Converting Enzyme Inhibitor Treatment on 1-Year Survival After Acute Myocardial Infarction: Findings of the PRIAMHO-II Registry

Revista Española de Cardiología (English Edition) ◽

10.1016/s1885-5857(06)60767-6 ◽

2006 ◽

Vol 59 (4) ◽

pp. 313-320

Author(s):

Fernando Arós ◽

Ángel Loma-Osorio ◽

Joan Vila ◽

Lorenzo López-Bescós ◽

José Cuñat ◽

...

Keyword(s):

Myocardial Infarction ◽

Beta Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Inhibitor Treatment

DOES ORAL BETA-BLOCKER THERAPY IMPROVE LONG-TERM CLINICAL OUTCOMES OF ST-ELEVATION ACUTE MYOCARDIAL INFARCTION AFTER PRIMARY ANGIOPLASTY?

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(10)61963-8 ◽

2010 ◽

Vol 55 (10) ◽

pp. A208.E1962

Author(s):

Neiko Ozasa ◽

Kazuaki Mitsudo ◽

Takeshi Morimoto ◽

Hou Heigen ◽

Toshihiro Tamura ◽

...

Keyword(s):

Myocardial Infarction ◽

Clinical Outcomes ◽

Beta Blocker ◽

Primary Angioplasty ◽

Blocker Therapy ◽

Beta Blocker Therapy ◽

St Elevation ◽

Effects of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy After Hospital Discharge on Subsequent Rehospitalization for Acute Myocardial Infarction and Heart Failure

Congestive Heart Failure ◽

10.1111/j.1751-7133.2009.00092.x ◽

2009 ◽

Vol 15 (4) ◽

pp. 170-175 ◽

Cited By ~ 9

Author(s):

Gregory Hess ◽

Ronald Preblick ◽

Jerrold Hill ◽

Craig A. Plauschinat ◽

Joseph Yaskin

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Angiotensin Receptor Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Blocker Therapy

Relationship Between Beta-Blocker and Angiotensin-Converting Enzyme Inhibitor Dose and Clinical Outcome Following Acute Myocardial Infarction

Circulation Journal ◽

10.1253/circj.cj-14-0633 ◽

2015 ◽

Vol 79 (3) ◽

pp. 632-640 ◽

Cited By ~ 13

Author(s):

Sylvain Grall ◽

Loïc Biere ◽

Marie Le Nezet ◽

Jean-Marc Bouvier ◽

Pierre Lucas-Chauvelon ◽

...

Keyword(s):

Myocardial Infarction ◽

Clinical Outcome ◽

Beta Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Inhibitor Dose

AT1-Receptorblocker Versus Angiotensin Converting Enzyme Inhibitor in Acute Myocardial Infarction? Role of Dosage and Bradykinin on Remodeling, Hemodynamics and Mortality in the Rat Model

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)85064-4 ◽

1998 ◽

Vol 31 (2) ◽

pp. 311A

Author(s):

P Gaudron

Keyword(s):

Myocardial Infarction ◽

Rat Model ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor

Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study

American Heart Journal ◽

10.1016/j.ahj.2004.03.035 ◽

2004 ◽

Vol 148 (2) ◽

pp. 292-299 ◽

Cited By ~ 7

Author(s):

Kenji Ueshima ◽

Kennichi Fukami ◽

Katsuhiko Hiramori ◽

Saichi Hosoda ◽

Hiroshi Kishida ◽

...

Keyword(s):

Myocardial Infarction ◽

Secondary Prevention ◽

Japanese Population ◽

Enzyme Inhibitor ◽

Final Report ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor